Detalhe da pesquisa
1.
Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot study.
Reprod Biomed Online
; 44(1): 200-203, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799277
2.
Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration.
J Clin Med
; 10(24)2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34945090